Biosensors Market Regional Analysis:
North American Market Insights
The biosensors market in North America is predicted to account for the largest share of 40% over the discussed timeline, i.e. between 2026 and 2035. The magnifying patient pool is highly responsible for the rapid growth in this landscape, making it an attractive destination for doing business for both domestic and international leaders. On this note, in June 2024, Abbott announced its debut in the U.S. consumer biowearables industry by gaining FDA approval for its two new over-the-counter continuous glucose monitoring systems, Lingo and Libre Rio. The company further shared its plans to create a multi-functional sensor to detect both glucose and ketone, fostering a possibility of garnering USD 10.0 billion in revenue from its Libre portfolio by 2028.
According to the American Journal of Preventive Medicine, the overall age-standardized diabetes prevalence in the U.S. increased by 18.6% in 2022 from 2012. It also estimated the national financial exhaustion to surpass USD 412.9 billion by 2024. Another NLM study reported that the numbers of new and death cases of cancer across the country were 2,041,910 and 618,120 in 2025, respectively, where they were 2,001,140 and 611,720 in 2024. This multiplying demography, coupled with the increasing pharmaceutical advances, is propelling the augmentation of the U.S. in the market. In this regard, in September 2024, Monod Bio unveiled a rapid biosensor assay platform, NovoLISA, for life sciences research and diagnostics. This de Novo protein-linked instantaneous solution-based assay can deliver results in just 15 minutes.
APAC Market Insights
The Asia Pacific biosensors market is estimated to be the second largest revenue generator, with a significant pace of growth by the end of 2035. Its propagation is led by the growing health awareness in emerging healthcare landscapes such as India, China, and Japan. Moreover, as these health-conscious consumers become more eager to spend money on exercise programs & activities, natural food intake, health supplements, and specialized diets, the surge for smart monitoring electronics grows. The region is also becoming the production hub for this field with the increased need for quality management in the food & beverages industry. On this note, in January 2023, Universal Biosensors extended its Sentia wine testing platform by launching a new Fructose biosensor test.
India is augmenting the market with several innovations and its extended manufacturing capabilities. With support from the government on the domestic production of medical devices and academic excellence, the country is securing its position at the top of the list of global manufacturers. For instance, in July 2023, China and India were the 1st and 3rd largest exporters of wearables in the world, where India alone shipped over 100.0 million units (IBEF). The growing awareness about the integration of advanced technologies to enhance the accuracy of diagnosis is also contributing to the country’s progress. In this regard, in April 2025, a multi-institute research team, led by the Indian Institute of Technology Madras developed a new biosensor platform for detecting Pre-eclampsia in pregnant women.
